InspireMD Files 8-K/A Amendment on Officer/Director Changes
Ticker: NSPR · Form: 8-K/A · Filed: Sep 8, 2025 · CIK: 1433607
| Field | Detail |
|---|---|
| Company | Inspiremd, INC. (NSPR) |
| Form Type | 8-K/A |
| Filed Date | Sep 8, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-changes, director-changes, amendment, compensation
TL;DR
InspireMD filed an 8-K/A amendment detailing leadership changes and compensation arrangements.
AI Summary
InspireMD, Inc. filed an amendment (8-K/A) on September 8, 2025, related to events on July 30, 2025. The filing concerns the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements for certain officers. The company is incorporated in Delaware and its principal business address is in Miami, Florida.
Why It Matters
This amendment provides updated information regarding changes in the company's leadership and executive compensation, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings concerning officer and director changes can indicate internal shifts that may affect company strategy or stability.
Key Numbers
- 20250730 — Event Date (Earliest event reported in the filing)
- 20250908 — Filing Date (Date the amendment was filed)
Key Players & Entities
- InspireMD, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Miami, Florida (location) — Business address
FAQ
What specific officer or director positions were affected by this amendment?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', but the specific names and roles are not detailed in this excerpt.
What is the significance of an 8-K/A filing?
An 8-K/A filing is an amendment to a previously filed 8-K report, used to correct or supplement information previously disclosed.
When was the original event that this amendment pertains to?
The earliest event reported in this amendment occurred on July 30, 2025.
What is InspireMD, Inc.'s primary business sector?
InspireMD, Inc. is in the 'Surgical & Medical Instruments & Apparatus' sector, SIC code 3841.
Where is InspireMD, Inc. headquartered?
InspireMD, Inc.'s business address is located at 6303 Waterford District Drive, Suite 215, Miami, FL 33126.
Filing Stats: 514 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-09-08 16:05:16
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NSPR The Nasdaq
Filing Documents
- form8-ka.htm (8-K/A) — 41KB
- 0001493152-25-012805.txt ( ) — 204KB
- nspr-20250730.xsd (EX-101.SCH) — 3KB
- nspr-20250730_lab.xml (EX-101.LAB) — 33KB
- nspr-20250730_pre.xml (EX-101.PRE) — 22KB
- form8-ka_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: September 8, 2025 By: /s/ Marvin Slosman Name: Marvin Slosman Title: Chief Executive Officer